Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Patients with ANCA-associated vasculitis (AAV) face more than double the risk of cardiovascular and thromboembolic events compared to healthy peers, a large Swedish study finds. The risks aren't equal across sexes — men with GPA are more prone to heart attacks, while women face higher stroke risk. Experts say earlier surveillance and monitoring are key.
A large population-based study out of Sweden has found that patients with ANCA-associated vasculitides (AAV) — a group of systemic autoimmune disorders — face more than double the risk of cardiovascular disease and thromboembolism (CVD-TE) compared to matched healthy controls. The study tracked over 4,300 AAV patients and more than 21,000 controls using national healthcare data from 2005 to 2020.
The findings revealed notable sex-specific differences, particularly in granulomatosis with polyangiitis (GPA): men were significantly more likely to suffer a myocardial infarction, while women faced a higher risk of ischemic stroke and CVD-TE-related death. Both sexes showed elevated risks for deep vein thrombosis and pulmonary embolism. Importantly, siblings of AAV patients showed no excess CVD-TE risk, suggesting the elevated risk is disease-driven rather than familial.
By the Numbers
Why it matters: These findings underscore the need for proactive cardiovascular monitoring in AAV patients, with sex-tailored risk assessments. Clinicians managing autoimmune conditions should factor in CVD-TE surveillance as a standard part of AAV care.
